PharmaLex Denmark A/S: Financial statements 2019
CVR: 18652439
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 17,037,411 and a net result of DKK 3,695,302 compared with DKK 2,874,449 the year before. That is an increase of 27.2% compared with the year before. Equity in the 2019 report amounted to DKK 5,952,821. The solvency ratio was 48.1%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 17,037,411
- Profit/Loss
- DKK 3,695,302
- Equity
- DKK 5,952,821
- Total Assets
- DKK 12,386,822
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 17 mio. | 3.7 mio. | 6 mio. | 18 |
| 2018 | - | 13.4 mio. | 2.9 mio. | 4.1 mio. | 15 |
| 2017 | - | 14.5 mio. | -1.6 mio. | 1.2 mio. | 21 |
| 2016 | - | 22.4 mio. | 5.3 mio. | 6.6 mio. | 30 |
| 2015 | - | 17.6 mio. | 321 t. | 4.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
PharmaLex Denmark A/S has published its annual report for 2018. Gross profit came to DKK 13,391,778, and the net result was DKK 2,874,449.
About PharmaLex Denmark A/S
PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.